Simple care bundle may slash infections after bypass surgery

NCT ID NCT07003750

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests a specially designed set of infection-prevention steps (a 'bundle') for people undergoing coronary artery bypass graft (CABG) surgery. The goal is to see if this bundle reduces surgical wound infections, both superficial and deep. The trial includes 200 participants with coronary artery disease, diabetes, or high blood pressure, and excludes those with cancer or weakened immune systems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
surgical wound infection prevention bundle (customized care protocol)
What this could lead to
If effective, this bundle could become a standard practice to lower infection rates after heart bypass surgery, improving recovery and reducing complications.
What could go wrong
This is a single-center study with 200 participants, so results may not apply to all hospitals. The bundle's effectiveness depends on consistent staff adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sohag University Hospital

    Sohag, 82511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.